Fate Therapeutics Reports Third Quarter 2016 Financial Results
Nov 07, 2016 21:01 pm UTC| Business
IND Filed for FATE-NK100 Adaptive Natural Killer Cell Immunotherapy in Acute Myeloid Leukemia Orphan Drug Designations for ProTmune Granted by FDA and EMA ProTmune™ PROTECT Clinical Protocol Amended to Facilitate Path...
Nov 07, 2016 21:01 pm UTC| Business
New Leadership Focused on Increasing Commercial Potential of Proven Durasert™ Sustained Release Platform Company Continues Focus on MAA and NDA Filings for Uveitis Product in 2017 Conference Call and Webcast Today,...
L.B. Foster Reports Third Quarter Operating Results
Nov 07, 2016 21:01 pm UTC| Business
PITTSBURGH, Nov. 07, 2016 -- L.B. Foster Company (NASDAQ:FSTR), a leading manufacturer, fabricator, and distributor of products and services for rail, construction, energy, and utility markets, today reported its third...
Editas Medicine Announces Third Quarter 2016 Results and Update
Nov 07, 2016 21:01 pm UTC| Business
Further strengthened leadership team with appointments of Charles Albright, Ph.D., as Chief Scientific Officer, and Gerald Cox, M.D., Ph.D., as Chief Medical Officer CAMBRIDGE, Mass., Nov. 07, 2016 -- Editas...
Monroe Capital Corporation BDC Announces Strong Third Quarter Financial Results
Nov 07, 2016 21:01 pm UTC| Business
CHICAGO, Nov. 07, 2016 -- Monroe Capital Corporation (Nasdaq:MRCC) (“Monroe”) today announced its financial results for the third quarter ended September 30, 2016. Except where the context suggests otherwise, the...
Nov 07, 2016 21:01 pm UTC| Business
-- Completed Enrollment in Phase 3 Plazomicin Clinical Trials; Expect Results from EPIC and CARE Trials by End of 2016 -- -- Planning Plazomicin NDA Submission in the Second Half of 2017 -- -- Presented First Plazomicin...
OptimizeRx Corporation Reports Third Quarter 2016 Results
Nov 07, 2016 21:01 pm UTC| Business
ROCHESTER, Mich., Nov. 07, 2016 -- OptimizeRx Corp. (OTCQB:OPRX), a health technology software company whose premier content-delivery platform enables pharmaceutical companies to offer doctors valuable product...